Oscar Health (OSCR) Fundamental Analysis: Revenue, Earnings & Valuation

7.44 / 10

Outperform

Fundamental analysis rates OSCR as Outperform with a 7.44/10 score. Revenue‑to‑market, receivable turnover and asset efficiency are strong, while cash‑up is weak. Current ratio and interest coverage are robust, supporting an encouraging financial profile.

Analysis Checks(9/10)

Revenue-MV

Value1.89

Score2/3

Weight5.41%

1M Return1.31%

Net profit attributable to parent company shareholders / Net profit (%)

Value100.06

Score3/3

Weight12.87%

1M Return2.92%

Accounts receivable turnover ratio

Value23.61

Score3/3

Weight11.58%

1M Return2.64%

Cash-UP

Value-0.16

Score0/3

Weight-12.95%

1M Return-3.59%

Fixed assets turnover ratio

Value9771.06

Score3/3

Weight10.68%

1M Return2.46%

Interest coverage ratio (EBIT / Interest expense) (%)

Value34.91

Score2/3

Weight10.55%

1M Return2.44%

Diluted earnings per share (YoY growth rate %)

Value-1790.00

Score3/3

Weight22.05%

1M Return4.62%

Asset-MV

Value-0.55

Score2/3

Weight11.33%

1M Return2.63%

Net profit attributable to parent company shareholders (YoY growth rate %)

Value-1842.49

Score2/3

Weight17.48%

1M Return3.66%

Current ratio

Value3.80

Score3/3

Weight11.00%

1M Return2.53%

Is OSCR fundamentally strong?

OSCR scores 7.44/10 on fundamentals and holds a Discounted valuation at present. Backed by its -44.38% ROE, -3.79% net margin, -8.20 P/E ratio, 3.71 P/B ratio, and -1636.36% earnings growth, these metrics solidify its Outperform investment rating.